DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer-Reference-Cited by-同舟云学术

DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer

Published:2013-03-24 Issue:14 Volume:22 Page:2820-2828
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Church David N.,Briggs Sarah E.W.,Palles Claire,Domingo Enric,Kearsey Stephen J.,Grimes Jonathon M.,Gorman Maggie,Martin Lynn,Howarth Kimberley M.,Hodgson Shirley V.,Kaur Kulvinder,Taylor Jenny,Tomlinson Ian P.M.

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/22/14/2820/17259128/ddt131.pdf

Reference33 articles.

1. DNA replication fidelity;Kunkel;J. Biol. Chem.,2004

2. Yeast DNA polymerase epsilon participates in leading-strand DNA replication;Pursell;Science,2007

3. Division of labor at the eukaryotic replication fork;McElhinny;Mol. Cell.,2008

4. Genome-wide model for the normal eukaryotic DNA replication fork;Larrea;Proc. Natl Acad. Sci. USA,2010

5. The major roles of DNA polymerases epsilon and delta at the eukaryotic replication fork are evolutionarily conserved;Miyabe;PLoS Genet.,2011

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification;Gynecologic Oncology;2024-12

2. A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation;Signal Transduction and Targeted Therapy;2024-09-02

3. The game-changing impact of POLE mutations in oncology—a review from a gynecologic oncology perspective;Frontiers in Oncology;2024-08-22

4. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer;Annals of Oncology;2024-07

5. Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer;Expert Review of Anticancer Therapy;2024-06-14